
HBS Reporting
Fauci says vast majority of vaccinated Americans should get a COVID-19 booster
-
HBS Reporting
U.S. FDA approves Gilead cell therapy for earlier lymphoma
Apr 4, 2022April 1 (Reuters) – The U.S. Food and Drug Administration on Friday approved expanded use of...
-
HBS Reporting
Shanghai separates COVID-positive children from parents in virus fight
Apr 4, 2022SHANGHAI, April 2 (Reuters) – Esther Zhao thought she was doing the right thing when she...
-
HBS Reporting
Vaccination after COVID improves immunity; ivermectin fails in major trial
Apr 4, 2022(Reuters) – The following is a summary of some recent studies on COVID-19. They include research...
-
HBS Reporting
Deliberate infection trial finds COVID symptoms don’t indicate viral shedding
Apr 4, 2022April 1 (Reuters) – The world’s first “human challenge” trial in which volunteers were deliberately exposed...
-
HBS Reporting
Sanofi to float drug ingredients manufacturing business on May 6
Apr 4, 2022Summary * Sanofi shareholders get 1 EUROAPI share for 23 shares in parent * Sanofi CFO...
-
HBS Reporting
England’s COVID-19 prevalence hits record high – ONS
Apr 4, 2022LONDON, April 1 (Reuters) – The prevalence of COVID-19 among people in England rose to its...
-
HBS Reporting
Bayer to invest 2 bln euros in drug production over next 3 years
Apr 1, 2022FRANKFURT, March 31 (Reuters) – German drugmaker Bayer (BAYGn.DE) said it would invest around 2 billion...
-
HBS Reporting
Rare upsurge in bird flu makes for worst-ever crisis in France
Apr 1, 2022PARIS, March 31 (Reuters) – France is facing its worst bird flu crisis in history as...
-
HBS Reporting
New cancer immunotherapy fails in first Roche trial
Mar 30, 2022Summary* Drug class has also attracted GSK, BMS, Gilead* Anti-TIGIT fails to quell aggressive lung tumours*...
-
HBS Reporting
China truckers use fake records, ‘clean’ drivers to dodge COVID rules
Mar 30, 2022BEIJING, March 30 (Reuters) – Chinese truck drivers hoping to outwit COVID-19 inspectors are faking travel...